在帕金森氏症中,GPNMB,LRRK2和 lysosome exocytosis 在帕金森氏症中
1Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305-5307, USA and Aligning Science Across Parkinson's, Chevy Chase, MD 20815 USA.
Science advances
|December 17, 2025
概括
帕金森病的风险基因会影响溶解体,导致GPNMB蛋白质的释放. 这种释放可能有助于α-synuclein的积累,这是帕金森病理学的标志.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特征是α-synuclein聚合.
- 遗传因素,包括LRRK2的突变,是PD风险的重要贡献者.
- 溶解体在细胞废物降解中起着至关重要的作用,它们的功能障碍与PD病变发生有关.
研究的目的:
- 研究与帕金森病风险相关的基因与 lysosomal 功能之间的相互作用.
- 阐明LRRK2突变影响 lysosomes 蛋白质释放的机制.
- 确定 lysosomal GPNMB释放对帕金森病中的α-synuclein病理学的潜在贡献.
主要方法:
- 利用表达与帕金森病风险相关的基因的细胞模型.
- 研究了 lysosomes 内特定蛋白质的局部化.
- 在不同条件下从细胞中量化可溶性甘氨酸甘氨酸结合膜蛋白 (GPNMB) 的释放.
- 评估了GPNMB对α-synuclein聚合的影响.
主要成果:
- 发现两种帕金森风险基因汇聚在溶酶体上.
- 观察到LRRK2突变可以增强溶性GPNMB的溶酶体释放.
- 提高可溶性GPNMB水平与增加的α-synuclein病理相关.
结论:
- 帕金森病风险基因在溶酶体上的融合突出了帕金森病中关键的细胞通路.
- 通过LRRK2介导的GPNMB释放的增强代表了一种新的机制,有助于合成核蛋白病变.
- 向溶酶体功能和GPNMB释放可能为帕金森病提供治疗策略.
相关概念视频
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:24Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
01:37Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
01:36Delivery Pathways to the Lysosome
8.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K